These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3320851)

  • 1. [Analysis of the effectiveness and adverse effects of the drug combinations CAP and CEP in the therapy of patients in the advanced stages of ovarian cancer].
    Hernádi Z; Juhász B; Póka R; Mahunka I; Lampé L
    Orv Hetil; 1987 Nov; 128(47):2457-61. PubMed ID: 3320851
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of 2 different forms of chemotherapy on remission in patients with advanced ovarian cancer].
    Krommer K; Keller G; Csaba I; Garadnay B; Göcze P
    Zentralbl Gynakol; 1990; 112(17):1105-10. PubMed ID: 2264421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of intervention surgery in stage III-IV epithelial ovarian carcinoma.
    Hoogland H; Blijham G; Bron H; Eekhout A; van Geuns H; Haest J; Huiskes H; Kornman J; de Koning Gans H; Lalisang F
    Prog Clin Biol Res; 1985; 201():213-5. PubMed ID: 3841592
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose intensity regimens with epirubicin in ovarian cancer.
    Vermorken JB
    Pathol Biol (Paris); 1992 Nov; 39(9):833. PubMed ID: 1538894
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of patients with advanced ovarian cancer at the Gynecological Clinic of Pécs Medical University].
    Krommer K
    Orv Hetil; 1992 May; 133(19):1151-8. PubMed ID: 1584596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of the first Austrian multicenter ovarian cancer study: prospective randomized comparison of sequential chemotherapy (adriamycin/cisplatin--vincristine/cyclophosphamide--methotrexate) with 2 standard protocols (adriamycin/cyclophosphamide or adriamycin/cisplatin) in stage III and IV patients].
    Salzer H; Gitsch E; Dittrich C; Sevelda P; Karrer K; Schemper M; Stempel-Smekal G; Langer M; Wagner G; Rainer H
    Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):761-8. PubMed ID: 3908214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)--the mount sinai experience.
    Cohen CJ; Bruckner HW; Goldberg JD; Holland JF
    Clin Obstet Gynaecol; 1983 Aug; 10(2):307-24. PubMed ID: 6413114
    [No Abstract]   [Full Text] [Related]  

  • 8. [A pilot trial of high dose CEP (cyclophosphamide, epirubicin, cis-platinum) therapy in patients with advanced and recurrent ovarian cancer].
    Hiura M; Ogawa M; Nozawa S; Kudo R; Kuwabara Y; Takahashi T; Takayama M; Tateno M; Ohashi Y; Yakushiji M
    Gan To Kagaku Ryoho; 2000 Apr; 27(4):585-91. PubMed ID: 10791001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of cepharanthin on leukopenia and thrombocytopenia caused by CDDP-ACR-CPA therapy of ovarian cancer].
    Ushiki N; Jobo T; Shimoda T; Kuramoto H; Arai M
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2701-6. PubMed ID: 3415268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
    Barlow JJ; Lele SB
    Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined chemotherapy including platinum derivatives in the combined treatment of patients with stage-III to -IV ovarian cancer].
    Perevodchikova NI; Gorbunova VA; Grigorova TM; Kozachenko VP; Marenich AF
    Vestn Akad Med Nauk SSSR; 1986; (5):8-11. PubMed ID: 3755271
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapeutic treatment of advanced ovarian carcinoma. Preliminary results of the Piedmont-Liguria Cooperative Group].
    Conte PF; Rosso R; Bruzzone M; Sertoli MR; Rubagotti A; Santi L; Carnino F; Cottini M; Mossetti C; Gatti M
    Minerva Ginecol; 1984 Apr; 36(4):213-6. PubMed ID: 6547773
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of patients with ovarian carcinoma: experimental and clinical studies].
    Kikuchi Y; Kita T; Iwano I; Miyauchi M; Oomori K; Kizawa I; Kato K
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jul; 40(7):933-5. PubMed ID: 3418201
    [No Abstract]   [Full Text] [Related]  

  • 14. Ovarian epithelial tumors of low malignant potential.
    Chien RT; Rettenmaier MA; Micha JP; DiSaia PJ
    Surg Gynecol Obstet; 1989 Aug; 169(2):143-6. PubMed ID: 2756462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controlled prospective study of chemotherapy in advanced ovarian cancer--cyclophosphamide monochemotherapy versus polychemotherapy with adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate].
    Chylak V; Kolarić K; Krusić J
    Lijec Vjesn; 1987 Jun; 109(6):230-4. PubMed ID: 3309515
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy induced refractory anaemia with ring sideroblasts in carcinoma breast.
    Dhot PS; Sharma MC; Kumar L; Saxena R
    J Assoc Physicians India; 1994 Feb; 42(2):153-4. PubMed ID: 7860480
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinicopathological evaluation of preoperative chemotherapy with doxorubicin plus cyclophosphamide followed by paclitaxel for locally advanced breast cancer].
    Miyake T; Miyahara S; Fujii K; Taniguchi M; Yamamura K; Tadokoro K; Tanimura M; Nakamura H
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):401-5. PubMed ID: 19295263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy in the management of ovarian germ cell malignancies.
    Schwartz PE
    Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
    Harper P
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of 28 years of treating advanced ovarian cancer.
    Krommer CF; Szalai JP
    Anticancer Res; 1993; 13(3):817-25. PubMed ID: 8317918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.